Arterial calcification and stiffness in chronic kidney disease (Q36854161)

16 August 2017

1 reference

title

Arterial calcification and stiffness in chronic kidney disease (English)

1 reference

16 August 2017

Kerr PG

1

1 reference

PubMed ID

17581230

16 August 2017

Guerin AP

series ordinal

2

1 reference

16 August 2017

1 July 2007

1 reference

Clinical and Experimental Pharmacology and Physiology

16 August 2017

1 reference

16 August 2017

34

1 reference

16 August 2017

7

1 reference

16 August 2017

683-687

1 reference

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Time and exercise improve phosphate removal in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Phosphate regulation of vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Molecular mechanisms of vascular calcification: lessons learned from the aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Osteopontin: a versatile regulator of inflammation and biomineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Mitigation of ectopic calcification in osteopontin-deficient mice by exogenous osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

"Phosphatonins" and the regulation of phosphorus homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Vascular calcification: mechanisms and clinical ramifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Arterial function after successful renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Natural history of vascular calcification in dialysis and transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

Evidence for Heritability of Abdominal Aortic Calcific Deposits in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04660.X

10.1111/J.1440-1681.2007.04660.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17581230